SBC Medical Group Holdings Incorporated
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $173.6M | $205.4M | $193.5M |
| Cost of Revenue | $46.3M | $49.4M | $56.2M |
| Gross Profit | $127.3M | $156.1M | $137.3M |
| Gross Margin | 73.3% | 76.0% | 70.9% |
| Operating Expenses | |||
| Research & Development | — | — | — |
| SG&A Expense | $59.8M | $57.7M | $66.2M |
| Operating Income | $67.5M | $70.3M | $70.7M |
| Operating Margin | 38.9% | 34.2% | 36.5% |
| Interest Expense | $148.2K | $28.3K | $45.3K |
| Pretax Income | $82.1M | $73.5M | $73.6M |
| Income Tax Expense | $31.0M | $26.8M | $35.0M |
| Net Income | $51.0M | $46.6M | $39.4M |
| Net Margin | 29.4% | 22.7% | 20.3% |
| EPS (Basic) | $0.50 | $0.48 | $0.42 |
| EPS (Diluted) | $0.50 | $0.48 | $0.42 |
| Shares Outstanding (Basic) | 103.0M | 96.6M | 94.2M |
| Shares Outstanding (Diluted) | 103.0M | 96.6M | 94.2M |
| Dividends Per Share | — | — | — |